RESEARCH

NANEXA: Funding secured as semaglutide pivot sharpens commercial focus

Analys, Research

Following the breakthrough license deal with Moderna, a global leader in mRNA therapeutics, in...

Read More

CRUNCHFISH: System-level positioning in place, commercial traction still pending

Analys, Research

Following last year’s breakthrough integration into India’s payment ecosystem, Crunchfish...

Read More

NANEXA: First license with Moderna an important validation of PharmaShell

Analys, Research

The announcement of Nanexa’s first licensing deal marks a meaningful validation of the...

Read More

NANEXA: Intensified focus on deals amid growing funding pressure

Analys, Research

Nanexa’s Q3 report underscores a pivotal moment for the company. While interest in its...

Read More

CINDRIGO HOLDINGS: Powering Europe’s clean baseload transition with LSE listing and first revenues

Research

Johan Widmark | 2025-10-30 17:00  Read the report in PDF here Executive Summary  With the...

Read More

PROLIGHT: Financing and partner interest strengthen case ahead of regulatory study

Analys, Research

Johan Widmark | 2025-08-29 08:00 READ REPORT IN PDF In Q2, Prolight reported initial positive data...

Read More

CRUNCHFISH: Improved outlook with NPCI adoption and global validation

Analys, Research

Crunchfish’s new go-to-market strategy for offline payments, splitting the solution into...

Read More

PROLIGHT: Positive patient data and patent approval strengthen case for Psyros

Analys, Research

Johan Widmark | 2025-06-18 08:00 READ REPORT IN PDF Key milestone for readiness Prolight has...

Read More